FC
TECH icon

Financial Consulate’s Bio-Techne TECH Stock Holding History

Financial Consulate’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,174
Closed -$61.4K – 1516
2026
Q1 		$61.4K Sell
1,174
-1,798
-60% -$108K 0.01% 291
2025
Q4 		$175K Sell
2,972
-940
-24% -$57.1K 0.02% 172
2025
Q3 		$218K Buy
+3,912
New +$210K 0.03% 156
2023
Q2 		– Sell
-6,141
Closed -$456K – 104
2023
Q1 		$456K Buy
6,141
+1,089
+22% +$83.9K 0.16% 74
2022
Q4 		$419K Buy
5,052
+132
+3% +$10.5K 0.15% 86
2022
Q3 		$349K Buy
4,920
+160
+3% +$13.8K 0.15% 77
2022
Q2 		$413K Buy
4,760
+828
+21% +$77.6K 0.19% 73
2022
Q1 		$426K Buy
3,932
+128
+3% +$13.2K 0.16% 78
2021
Q4 		$492K Buy
3,804
+36
+1% +$4.41K 0.17% 73
2021
Q3 		$456K Buy
3,768
+404
+12% +$49.2K 0.17% 70
2021
Q2 		$379K Buy
3,364
+12
+0.4% +$1.26K 0.14% 78
2021
Q1 		$320K Buy
3,352
+624
+23% +$56.9K 0.13% 78
2020
Q4 		$217K Buy
+2,728
New +$198K 0.09% 98

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Financial Consulate's TECH Position: Q2 2026 in Review

Financial Consulate sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 1,174 shares — an estimated $61.4K sold.

Financial Consulate first reported a position in TECH in Q4 2020 and held it in 13 quarters. The position peaked at $492K in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Financial Consulate reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Financial Consulate sold 1,174 Bio-Techne shares in Q2 2026, an estimated $61.4K.
  • Financial Consulate first reported a position in Bio-Techne in Q4 2020 and held it in 13 quarters.
  • Financial Consulate's Bio-Techne position peaked at $492K in Q4 2021.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.